SCHEMBL13638454

SCHEMBL13638454

C=C1CC(Nc2nccc(-c3ccc(Br)s3)n2)CC(C)(C)N1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDK4 P11802 9/20 0.36
CDK2 P24941 9/20 0.36
CDK1 P06493 7/20 0.36
CCNB1 P14635 7/20 0.36
CCNA2 P20248 7/20 0.36
CCND1 P24385 7/20 0.36
CCNA1 P78396 6/20 0.36
CCND3 P30281 3/20 0.34
CDK6 Q00534 3/20 0.34
CCNE1 P24864 1/20 0.34
IKBKB O14920 3/20 0.33
MAPK10 P53779 6/20 0.32
MAPK8 P45983 6/20 0.32
MAPK9 P45984 5/20 0.32
GSK3B P49841 3/20 0.31
MAPK14 Q16539 2/20 0.31
MAP2K7 O14733 1/20 0.31
MAPK13 O15264 1/20 0.31
MAP2K4 P45985 1/20 0.31
MAPKAPK2 P49137 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14612785 0.88 IKBKB (0.37) CDK4CDK2CDK1CCNB1CCNA2
SCHEMBL13638286 0.86 ROCK2 (0.35) CDK4CDK2CDK1CCNB1CCNA2
SCHEMBL13638420 0.86 KDM4E (0.38) CDK4CDK2CDK1CCNB1CCNA2
SCHEMBL13638579 0.85 SRC (0.35) CDK4CDK2CDK1CCNB1CCNA2
SCHEMBL13638669 0.85 CDK2 (0.36) CDK4CDK2CDK1CCNB1CCNA2
SCHEMBL4487841 0.85 KCNH2 (0.40) CDK4CDK2CDK1CCNB1CCNA2
SCHEMBL13638672 0.84 CDK1 (0.40) CDK4CDK2CDK1CCNB1CCNA2
SCHEMBL14612849 0.84 IKBKB (0.35) CDK4CDK2CDK1CCNB1CCNA2
SCHEMBL13638428 0.84 CDK4 (0.42) CDK4CDK2CDK1CCNB1CCNA2
SCHEMBL13638295 0.84 AKT3 (0.38) CDK4CDK2CDK1CCNB1CCNA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7615562-B2 Such as 2-methyl-4-{5-[2-(2,2,6,6-tetramethyl-piperidin-4-ylamino)-pyrimidin-4-yl]-thiophen-2-yl}-butan-2-ol; tumor necrosis factor inhibitors; immunosuppressants; antiinflammatory agents NOVARTIS AG (CH) 2009-11-10 US disclosed